BBLG News and Press, Bone Biologics Corp From 06/15/23

2023-06-15 08:24:35 ET Mersana Therapeutics ( MRSN ) -67% on FDA partial hold on trials for lead asset. Bone Biologics Corporation ( BBLG ) -53% on offering prices of $5M . Gambling.com Group Limited ( GAMB ) -15% launches secondary offering of 4....

2023-06-15 05:35:03 ET Bone Biologics ( NASDAQ: BBLG ) prices an underwritten public offering of ~2.54M shares at a price to the public of $1.97 per share. Aggregate gross proceeds of ~$5M. Underwriters have a 45 days option to purchase up to an additional 253,807 shar...

Bone Biologics Corporation (NASDAQ: BBLG) (“Bone Biologics” or the “Company”) , a developer of orthobiologic products for spine fusion markets, today announced the pricing of an underwritten public offering of common stock. Bone Biologics is selling 2,538,071 share...

2023-06-14 10:03:06 ET Gainers: Inventiva ( IVA ) +25% . Gossamer Bio ( GOSS ) +21% . Akoya Biosciences ( AKYA ) +19% . InVivo Therapeutics ( NVIV ) +14% . Bone Biologics ( BBLG ) +13% . Losers: IO Biotech ( IOBT ...

2023-06-08 10:04:22 ET Gainers: Aclarion ( ACON ) +35% . Bone Biologics ( BBLG ) +17% . Atara Biotherapeutics ( ATRA ) +16% . Medigus ( MDGS ) +15% . AVITA Medical ( RCEL ) +13% . Losers: Panbela Therapeutics ( PBLA ) ...

2023-06-08 08:33:44 ET Baosheng Media Group Holdings  ( BAOS ) +99% . Alithya Group  ( ALYA ) +38% Q4 earnings call release Onfolio Holdings ( ONFO ) +21% Acquisition Strategy Update and Further Outlines AI Strategy on its Corporate Website. R...

Bone Biologics Corporation (NASDAQ: BBLG) , a developer of orthobiologic products for spine fusion markets, announces that a 1-for-30 reverse stock split became effective on June 5, 2023 and that its common stock and warrants will begin trading on a split-adjusted basis with the open of the m...

Company plans to begin 30-patient trial later this year Bone Biologics Corporation (NASDAQ: BBLG) , a developer of orthobiologic products for spine fusion markets, announces that the Human Research Ethics Committee (HREC) has approved Monash Health as the first of a planned multicen...

Bone Biologics Corporation (NASDAQ: BBLG) , a developer of orthobiologic products for spine fusion markets, announces it has engaged Avania as the contract research organization (CRO) for the Company’s pilot clinical trial with NB1. Avania is an integrated global, full-service CRO with s...

This article is about penny stocks under $1; they can be purchased for pennies, but does that mean they’re worth it? You can decide for yourself based on your trading strategy. This niche within the stock market today has grown in popularity over the last few months. Due to the 2022 st...